ATRX and neuroblastoma: In addition to human NB, loss-of-function (LoF) mutations in ATRX have frequently been detected in multiple malignancies [4–7], and have been implicated in the telomerase-independent telomere maintenance alternative lengthening of telomeres (ALT) mechanism, which has been reported in 24% of high-risk NB [8–10].